Cargando…

Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation

OBJECTIVES: Graves’ disease is secondary to the presence of anti-thyrotropin receptor antibodies (TRAb), which stimulate thyroid hormones. TRab determination is crucial for etiological diagnosis. The objectives of this study were (i) to compare two methods for determining TRab by chemoluminiscence v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silvestre, Ramona A., Almería Lafuente, Alejandro, Jiménez-Mendiguchía, Lucía, García-Cano, Ana, Romero López, Rubén, García-Izquierdo, Belén, Pardo de Santayana, Cristina, Iglesias, Pedro, Diez, Juan J., Arribas Gómez, Ignacio, Bernabeu-Andreu, Francisco A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197409/ https://www.ncbi.nlm.nih.gov/pubmed/37363331 http://dx.doi.org/10.1515/almed-2021-0015

Ejemplares similares

Comparación de tres métodos para la medida de la concentración de anticuerpos anti-receptor de tirotropina (TRAb) en el diagnóstico de la enfermedad de Graves. Validación clínica
por: Silvestre, Ramona A., et al.
Publicado: (2020)

Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein–Barr Virus Reactivation
por: Kumata, Keisuke, et al.
Publicado: (2016)

The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021)

Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
por: Shahida, Bushra, et al.
Publicado: (2021)

SAT462 TSI Versus TRAb In The Diagnosis Of Grave’s Disease
por: Ibrahim, Katherine, et al.
Publicado: (2023)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

RhoA with Associated TRAb or FT3 in the Diagnosis and Prediction of Graves' Ophthalmopathy
por: Zhao, Sidi, et al.
Publicado: (2022)

Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’ disease
por: Chen, Xinxin, et al.
Publicado: (2018)

Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020)

Thymic Involution After Radioiodine Therapy for Graves Disease: Relationships With Serum Thyroid Hormones and TRAb
por: Jinguji, Megumi, et al.
Publicado: (2017)

Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021)

The Potential Link between Gut Microbiota and Serum TRAb in Chinese Patients with Severe and Active Graves' Orbitopathy
por: Shi, Ting-Ting, et al.
Publicado: (2019)

Evaluation of TRAb and TSI Leves and Thyroid Function in Pregnant Women With Graves’ Disease and Newborn: Preliminary Data
por: Negri, Maurício Massucati, et al.
Publicado: (2021)

Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
por: Cho, Won Yong, et al.
Publicado: (1988)

Age moderates the associations between TRAbs, free T3 and outcomes of Graves’ disease patients with radioactive iodine treatment
por: Lu, Lusi, et al.
Publicado: (2020)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
por: Kahaly, George J, et al.
Publicado: (2019)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

Sampling trabecular meshwork using TrabEx+
por: Ramjiani, Vipul, et al.
Publicado: (2021)

Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave’s Disease in Basrah
por: Radhi, Maher A, et al.
Publicado: (2023)

Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity
por: Song, Young Shin, et al.
Publicado: (2016)

TSH Receptor Antibodies (TRAb) Assay: An Underutilized Test in India
por: Jacob, Jubbin Jagan
Publicado: (2022)

Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
por: Cho, Bo Youn, et al.
Publicado: (1990)

Thyrotropin-producing pituitary adenoma simultaneously existing with Graves’ disease: a case report
por: Arai, Nobuhiko, et al.
Publicado: (2017)

MON-593 Thyrotropin Receptor Stimulating Immunoglobulin: Clinical Utility in Graves' Disease Diagnosis
por: Marques, Bernardo, et al.
Publicado: (2019)

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease
por: Xu, Shiji, et al.
Publicado: (2023)

Case report of recurrent atrial fibrillation induced by thyrotropin-secreting pituitary adenoma with Graves’ disease
por: Li, Jiaqi, et al.
Publicado: (2018)

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
por: Pearce, Simon H.S., et al.
Publicado: (2019)

SAT-557 Functional Thyrotropin Receptor Antibodies Confirm a Novel Graves' Disease Animal Model
por: Diana, Tanja, et al.
Publicado: (2019)

Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA
por: Zhao, Shuang-Xia, et al.
Publicado: (2011)

Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease
por: Kim, Jinyoung, et al.
Publicado: (2021)

Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment
por: Tsukada, Daichi, et al.
Publicado: (2022)

ELF3-induced miR-182 inhibits adipogenic differentiation in Graves’ orbitopathy by targeting thyrotropin receptor
por: Wang, Sha, et al.
Publicado: (2023)

IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid
por: Donoso-Navarro, Encarnación, et al.
Publicado: (2021)

SAT-555 Cytotoxicity of Epstein-Barr Virus Reactivation-Induced TRAb-IgM to Thyrocytes
por: Nagata, Keiko, et al.
Publicado: (2019)

The influence of hepatitis C infection and interferon-α therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report
por: Tran, Huy A, et al.
Publicado: (2009)

Presence of Epstein–Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves’ disease patients and in healthy individuals
por: Nagata, Keiko, et al.
Publicado: (2014)

Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature
por: Fu, Jinrong, et al.
Publicado: (2020)

Antioxidant Activity of Myrtus communis L. and Myrtus nivellei Batt. & Trab. Extracts: A Brief Review
por: Hennia, Aicha, et al.
Publicado: (2018)

Combined Visco-Trab operation: A dual filtration pathway for management of advanced glaucoma—midterm results
por: Eid, Tarek M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8pd28iib8hlmlrniecokdoo2or